Combined therapy with RAD001 e BEZ235 overcomes resistance of PET immortalized cell lines to mTOR inhibition. [electronic resource]
Producer: 20150605Description: 5381-91 p. digitalISSN:- 1949-2553
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Everolimus
- Humans
- Imidazoles -- administration & dosage
- Neuroendocrine Tumors -- drug therapy
- Pancreatic Neoplasms -- metabolism
- Phosphorylation
- Quinolines -- administration & dosage
- Signal Transduction
- Sirolimus -- administration & dosage
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.